Archean Chemical Industries Limited Approves Merger of Subsidiaries
March 20, 2026 – Archean Chemical Industries Limited announced that its Board of Directors has approved the merger of its wholly-owned subsidiary, Idealis Chemicals Private Limited (ICPL), with its wholly-owned subsidiary, Idealis Mudchemie Private Limited (IMPL). The merger will be implemented in accordance with the Companies Act, 2013, the Income Tax Act, 1961, and other applicable laws.ICPL, incorporated on October 5, 2023, is involved in the manufacturing of various chemical products. IMPL provides services including drilling, work over, geological surveys, pipeline construction, and mud engineering. Both companies have registered offices located at No. 2, North Crescent Road, T.Nagar, Chennai, Tamil Nadu, India, 600017.
The rationale for the merger includes simplifying the group structure, consolidating operations, improving efficiency, and strengthening the balance sheet. Given that ICPL already holds the entire share capital of IMPL, the merger represents an internal restructuring, with a notional share exchange ratio of 1:1. The transaction will not result in any change in the shareholding pattern of Archean Chemical Industries Limited.
Table: Details of Merger
| Particulars | Idealis Chemicals Private Limited (ICPL) | Idealis Mudchemie Private Limited (IMPL) |
|---|---|---|
| Name of the entity(ies) | Transferor Company | Transferee Company |
| Area of Business | Manufacturing of various chemical products | Drilling, work over, geological surveys, pipeline construction and mud engineering |
| Rationale for amalgamation | To simplify group structure, consolidate operations and improve efficiency | To simplify group structure, consolidate operations and improve efficiency |
| Share Exchange Ratio | Notional 1:1 | Notional 1:1 |
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.